Antithrombin III (AT III) prevents increased permeability and leukocyte adhesion in response to endotoxin (LPS) in the microcirculation of rat mesentery

Crit Care · 1999 · PMC3301801

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Background Clinical trials with substitution of AT III in patients with sepsis showed a trend towards reduction of mortality and a positive effect on development and course of multiple organ failure.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.